Eastman Chemical Company (NYSE:EMN) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Eastman Chemical Company (NYSE:EMN) have earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $80.25.

Several analysts have recently commented on EMN shares. Royal Bank Of Canada raised their price objective on shares of Eastman Chemical from $79.00 to $82.00 and gave the company a “sector perform” rating in a research report on Tuesday, May 5th. Mizuho set a $85.00 price target on Eastman Chemical in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $82.00 price objective on shares of Eastman Chemical in a research report on Tuesday, May 5th. Evercore set a $75.00 target price on Eastman Chemical in a research report on Wednesday, February 18th. Finally, Weiss Ratings raised Eastman Chemical from a “sell (d+)” rating to a “hold (c)” rating in a research note on Wednesday, February 18th.

Eastman Chemical Stock Down 1.3%

NYSE EMN opened at $71.54 on Friday. The stock’s 50-day moving average price is $72.29 and its 200-day moving average price is $68.86. The company has a market capitalization of $8.18 billion, a P/E ratio of 20.74, a price-to-earnings-growth ratio of 0.92 and a beta of 1.04. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.73. Eastman Chemical has a 52 week low of $56.11 and a 52 week high of $83.47.

Eastman Chemical (NYSE:EMN) last released its earnings results on Thursday, April 30th. The basic materials company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.02. Eastman Chemical had a net margin of 4.62% and a return on equity of 8.88%. The company had revenue of $2.18 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same period in the prior year, the firm posted $1.91 EPS. The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. Eastman Chemical has set its Q2 2026 guidance at 1.700-1.900 EPS. On average, equities research analysts predict that Eastman Chemical will post 6.33 earnings per share for the current year.

Eastman Chemical Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Stockholders of record on Monday, June 15th will be issued a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Monday, June 15th. Eastman Chemical’s payout ratio is 97.39%.

Hedge Funds Weigh In On Eastman Chemical

Several institutional investors have recently bought and sold shares of the stock. MUFG Securities EMEA plc purchased a new stake in Eastman Chemical in the 2nd quarter worth $25,000. Altshuler Shaham Ltd bought a new stake in shares of Eastman Chemical in the fourth quarter worth about $25,000. Brown Lisle Cummings Inc. increased its holdings in shares of Eastman Chemical by 70.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 425 shares of the basic materials company’s stock worth $27,000 after purchasing an additional 175 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Eastman Chemical in the fourth quarter worth about $27,000. Finally, Los Angeles Capital Management LLC bought a new position in Eastman Chemical during the fourth quarter valued at approximately $27,000. 83.65% of the stock is owned by hedge funds and other institutional investors.

More Eastman Chemical News

Here are the key news stories impacting Eastman Chemical this week:

• Positive Sentiment: Zacks Research raised Eastman Chemical’s FY2026 EPS estimate to $5.81 from $5.61, suggesting improved earnings expectations for the current fiscal year.
• Positive Sentiment: The firm also increased its Q2 2026 estimate to $1.70 from $1.57 and Q3 2026 to $1.69 from $1.64, pointing to better near-term profitability.
• Positive Sentiment: Longer-range estimates were lifted for Q2 2027, Q3 2027, and Q4 2027, as well as FY2027, with FY2027 now expected at $6.59 per share versus $6.56 previously.
• Neutral Sentiment: Zacks Research kept a Hold rating on EMN, so the revisions were not accompanied by a bullish rating change.
• Neutral Sentiment: The stock is still near its recent trading range, and the analyst consensus for current-year earnings remains at $6.33 per share, leaving some uncertainty about whether revisions are enough to re-rate the shares.
• Negative Sentiment: Not all changes were positive: Zacks lowered its Q1 2027 EPS estimate to $1.52 from $1.67 and cut its Q1 2028 estimate to $1.54 from $1.68, which may signal caution about later-period demand or margin trends.
• Negative Sentiment: FY2028 EPS was also trimmed to $7.09 from $7.18, reinforcing that the outlook is mixed beyond the next couple of years.

About Eastman Chemical

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.